Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Sight Sciences, Inc. Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy) June 21, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Two Year Multicenter Study Results Show Sustained Reductions in Both Intraocular Pressure (IOP) and Glaucoma Medication Use in Mild-Moderate Primary Open Angle Glaucoma Patients Treated with a Procedure Enabled with the OMNI® Surgical May 23, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry May 06, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023 May 04, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting May 01, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences to Present at the Upcoming Bank of America Securities 2023 Health Care Conference April 26, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023 April 20, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023 April 13, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer April 03, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers GLS PEAR SGHT Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office March 30, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results March 13, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System March 09, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023 February 23, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference February 22, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Announces 1,000th TearCare® Customer Installation January 26, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results January 09, 2023 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months December 08, 2022 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference November 22, 2022 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Reports Third Quarter 2022 Financial Results November 10, 2022 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure November 03, 2022 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022 October 20, 2022 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED) September 29, 2022 From Sight Sciences, Inc. Via GlobeNewswire Tickers SGHT Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.